These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37138546)

  • 1. Reconsidering the routine use of contact precautions in preventing the transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings.
    Rodriguez-Nava G; Diekema DJ; Salinas JL
    Infect Control Hosp Epidemiol; 2023 Jun; 44(6):1035-1037. PubMed ID: 37138546
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of standard, contact, and droplet precautions with eye protection for the prevention of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission among home healthcare personnel in hospice and home healthcare settings-King and Snohomish counties, Washington, February-October 2020.
    McMichael TM; Duca LM; Lewis J; Riedo FX; Wilde N; McDonald M; Spitters C; Wechkin HA
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):510-513. PubMed ID: 35264278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection prevention measures in acute care settings based on severe acute respiratory syndrome coronavirus 2 transmission patterns and risk: a review.
    Yen CF; van den Berg P; Pepe DE
    Curr Opin Infect Dis; 2021 Aug; 34(4):346-356. PubMed ID: 34127582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible contact transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings in Japan, 2020-2021.
    Kurosu H; Watanabe K; Kurosawa K; Nakashita M; Kasamatsu A; Nakamura H; Yamagishi T; Mitsuhashi Y; Yano K; Hachiya Y; Odani T; Amishima M; Nekomiya Y; Matsui T; Yamada M; Kamiyama K; Kikuchi T; Takadate K; Watanabe C; Furusawa Y; Kase K; Hyodo Y; Suzuki H; Matsunaga T; Hori H; Kanoh M; Miyake Y; Yamada M; Kobayashi Y; Sugai M; Suzuki M; Sunagawa T
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1296-1298. PubMed ID: 34039453
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care Settings.
    Winkler ML; Hooper DC; Shenoy ES
    Infect Dis Clin North Am; 2022 Jun; 36(2):309-326. PubMed ID: 35636902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal masking to control healthcare-associated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).
    Thompson ER; Williams FS; Giacin PA; Drummond S; Brown E; Nalick M; Wang Q; McDonald JR; Carlson AL
    Infect Control Hosp Epidemiol; 2022 Mar; 43(3):344-350. PubMed ID: 33775264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare-associated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among Thai healthcare personnel who receive 2 doses of a coronavirus disease 2019 (COVID-19) vaccine: A call for considering a booster dose.
    Apisarnthanarak A; Nantapisal S; Pienthong T; Apisarnthanarak P; Weber DJ
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1740-1742. PubMed ID: 34353405
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2), delta variant, between two fully vaccinated healthcare personnel.
    Smith LL; Milstone AM; Jibowu M; Luo CH; Morris CP; Mostafa HH; Maragakis LL
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1983-1985. PubMed ID: 34743764
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of healthcare personnel exposures to patients with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) associated with personal protective equipment.
    Shah VP; Breeher LE; Hainy CM; Swift MD
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):770-774. PubMed ID: 33975656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rostered routine testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel-Is there a role in a tertiary-care hospital with enhanced infection prevention and control measures and robust sickness-surveillance systems?
    Chow A; Guo H; Kyaw WM; Li AL; Lim RHF; Ang B
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1528-1530. PubMed ID: 34075868
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of research on air and environmental contamination with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings.
    Kanamori H
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):130-133. PubMed ID: 33298221
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of an antigen-test-based strategy to reduce duration of transmission-based precautions for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in hospitalized patients.
    Schrank GM; Harris-Williams M; Schiavone K; Lusby MC; Dove C; Leekha S
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):114-116. PubMed ID: 37539701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).
    Lüsebrink J; Schildgen V; Schildgen O
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1529-1532. PubMed ID: 33213555
    [No Abstract]   [Full Text] [Related]  

  • 14. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations.
    Talbot TR; Hayden MK; Yokoe DS; Malani AN; Amer HA; Kalu IC; Logan LK; Moehring RW; Munoz-Price S; Palmore TN; Weber DJ; Wright SB;
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):2-7. PubMed ID: 36539917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital outbreak of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant in partially and fully vaccinated patients and healthcare workers in Toronto, Canada.
    Susky EK; Hota S; Armstrong IE; Mazzulli T; Kestenberg S; Casaubon LK; Granton J; Rebelo C; Bartels E; Wrana J; Vaisman A
    Infect Control Hosp Epidemiol; 2023 Feb; 44(2):328-331. PubMed ID: 34706787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Healthcare Surface Environment in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Potential Control Measures.
    Kanamori H; Weber DJ; Rutala WA
    Clin Infect Dis; 2021 Jun; 72(11):2052-2061. PubMed ID: 32985671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status: nosocomial transmission and prevention of SARS-CoV-2 in a Danish context.
    Calum HP; Sode LP; Pedersen M
    APMIS; 2021 Jul; 129(7):340-351. PubMed ID: 34050990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retesting for severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Patterns of testing from a large US healthcare system.
    Kennedy AJ; Hilmes MK; Waddell L; Bartow AB; Baxter CM; Hadi CM; Snyder GM; Merlin JS
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):1023-1025. PubMed ID: 32772941
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection Prevention Precautions for Routine Anesthesia Care During the SARS-CoV-2 Pandemic.
    Bowdle A; Jelacic S; Shishido S; Munoz-Price LS
    Anesth Analg; 2020 Nov; 131(5):1342-1354. PubMed ID: 33079853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.